Volume 2, Number 2
This unique journal lets readers benefit from the experience and wisdom of preeminent professionals in university, legal and corporate settings.
Patent Reform: Effects on Medical Innovation Business
This Special Edition of Medical Innovation & Business was devoted to evaluating the potential consequences of the Patent Reform Act of 2010, as it moved through the House of Representatives to the Senate for passage. Experts from various fields of intellectual property law, medical research and venture capital contributed to this special edition, which was delivered to every member of Congress so they could make a more inform decision before casting their votes. This issue focused on how the passage of certain bills within this reform would negatively impact university research, university spin-offs, emerging start-ups and small life sciences companies, especially those in the medical sciences; and ultimately the U.S. economy.
IP Advocate opposed many provisions of patent reform because they reflected the interests of large market incumbents that have extensively lobbied Congress and may be skewed against start-ups, small companies, individual inventors, university researchers and their spin-offs. Adverse effects may arise, simply because important questions haven’t been addressed. Through the collaboration of IP Advocate and the Johns Hopkins Institute, this Special Edition invited experts to ask the hard questions and explore alternative policies that would encourage innovation to inspire an informed public debate.